<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Asia Pac Allergy</journal-id><journal-id journal-id-type="publisher-id">APA</journal-id><journal-title-group><journal-title>Asia Pacific Allergy</journal-title></journal-title-group><issn pub-type="ppub">2233-8276</issn><issn pub-type="epub">2233-8268</issn><publisher><publisher-name>Asia Pacific Association of Allergy, Asthma and Clinical Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3206235</article-id><article-id pub-id-type="pmid">22053291</article-id><article-id pub-id-type="doi">10.5415/apallergy.2011.1.1.12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Current Review</subject></subj-group></article-categories><title-group><article-title>Immunoglobulin E in health and disease</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Amarasekera</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Physiology, Faculty of Medicine, University of Kelaniya, Ragama 11010, Sri Lanka.</aff><author-notes><corresp>
Correspondence: M. Amarasekera. Department of Physiology, Faculty of Medicine, University of Kelaniya, Ragama 11010, Sri Lanka. Tel: +94-714143184, Fax: +94-112958337, <email>manori_a@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>19</day><month>4</month><year>2011</year></pub-date><volume>1</volume><issue>1</issue><fpage>12</fpage><lpage>15</lpage><history><date date-type="received"><day>18</day><month>11</month><year>2010</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The discovery of immunoglobulin E (IgE) was a breakthrough in the field of Allergy and Immunology. Our understanding of mechanisms of allergic reactions and the role of IgE in these disorders has paralleled to the discovery of treatment modalities for patients with allergy. Apart from allergic diseases, IgE is involved in pathogenesis of other disorders. Much controversy exists about the control of total IgE (tIgE) levels and allergen-specific IgE (sIgE) profiles in allergic individuals. This review aims at giving a comprehensive overview of IgE molecule and discussing the issues related to its importance in clinical setting.</p></abstract><kwd-group><kwd>Immunoglobulin E</kwd><kwd>Allergy</kwd></kwd-group></article-meta></front><body><sec><title>Basic characteristics of immunoglobulin E (IgE)</title><p>The discovery of IgE was made much later than the discovery of other immunoglobulin subclasses. The first clue to the existence of a substance responsible for hypersensitivity reactions was demonstrated in 1921 by Prausnitz and Kustner, and after only four decades (1967) it was identified as an immunoglobulin subclass by Ishizakas and co-workers [<xref ref-type="bibr" rid="B1">1</xref>]. In 1968, The WHO International Reference Centre for Immunoglobulins announced the presence of a fifth immunoglobulin isotype, IgE [<xref ref-type="bibr" rid="B2">2</xref>]. IgE is the antibody isotype that contains the &#x003b5; heavy chain and it is a monomer with five domains in the immunoglobulin structure. It is normally present in plasma at a concentration of less than 1 &#x000b5;g/mL and has a half-life of about 2 days in serum [<xref ref-type="bibr" rid="B3">3</xref>]. A new unit (kU/L or IU/mL) was introduced to express the level of IgE in peripheral blood to alleviate the inconvenience in expressing the very low levels of serum IgE. One kU/L is equal to 2.4 ng/mL [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>Once produced, IgE binds to its receptor Fc&#x003b5;R, which are of two main types. High-affinity receptors (Fc&#x003b5;RI) are found on wide variety of cells; mast cells, basophils, antigen presenting cells, monocytes and platelets [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>] whereas low-affinity receptors (Fc&#x003b5;RII) are found to be expressed on B-cells [<xref ref-type="bibr" rid="B7">7</xref>], monocytes [<xref ref-type="bibr" rid="B8">8</xref>] and dendritic cells [<xref ref-type="bibr" rid="B9">9</xref>]. The role of high affinity receptors in the pathogenesis of allergy is well understood [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B7">7</xref>] but the biological role of low-affinity receptors is still unclear.</p></sec><sec><title>The role of IgE in health and disease</title><p>IgE was discovered for its involvement in allergic reactions (Type I hypersensitivities). People, who have a tendency to develop symptoms when exposed to allergens, produce IgE specific to that allergen, which evokes a cascade of reactions [<xref ref-type="bibr" rid="B10">10</xref>]. In terms of evolution, it is highly unlikely that IgE evolved to contribute to the pathology of allergy, hence people started investigating the exact role of IgE in human. It has been shown that the dominant role of IgE is to protect the host from parasitic infections, specially helminth infections [<xref ref-type="bibr" rid="B11">11</xref>]. Hence it is believed that IgE has evolved to protect the human from helminth infections, which once was the major threat for the survival of the human species [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>].</p></sec><sec><title>Role of IgE in helminth infections</title><p>IgE plays a vital role in the cross-talk between innate and adaptive immunity. Helminths are large parasites that can not be engulfed by phagocytes and could be best dealt by cytotoxic cells. Invasion of tissues by helminths stimulates an immune response which generates a cytokine milieu that shifts the TH<sub>0</sub> cells to mature along the TH<sub>2</sub> pathway. These TH<sub>2</sub> cells secrete interleukin (IL) 4 which induces the B cells to switch the immunoglobulin class to IgE. At the same time secreted IL 5 enhances the production and maturation of eosinophils [<xref ref-type="bibr" rid="B14">14</xref>].</p><p>IgE molecules coat the parasite which enables the tissue mast cells and circulating eosinophils to bind via their IgE receptors. This interaction of IgE with their receptors initiates a cascade of reactions in these cells which results in release of histamine and other toxic substances to the exterior [<xref ref-type="bibr" rid="B15">15</xref>]. Eosionophils that are recruited to the site of infection release granule proteins such as major basic protein, eosinophil cationic protein. These toxic substance released from the cells in the vicinity of the invading parasite are capable of killing the parasite [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>].</p></sec><sec><title>IgE in allergic reactions</title><p>Understanding the role of IgE in allergic reaction has been a major breakthrough in the field of allergy. It has paved the way for the discovery of effective drugs for these diseases. The sequence of events in the allergic reaction consists of the production of IgE antibodies in response to an allergen, binding of IgE to Fc receptors of mast cells, cross-linking of the bound IgE by the allergen upon re-exposure, and release of mast cell mediators such as histamine, lipid mediators and cytokines. Some mast cell mediators cause rapid increase in vascular permeability and smooth muscle contraction, resulting in many of the symptoms [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>].</p><p>The above reaction does not take place in every individual when exposed to environmental allergens. People with a genetic predisposition, called atopics, have a personal tendency to develop IgE when exposed to otherwise harmless environmental allergens. Such individuals have allergen-specific IgE (sIgE) in their serum reflecting their exposure to allergens in the past [<xref ref-type="bibr" rid="B10">10</xref>].</p></sec><sec><title>Levels of total IgE (tIgE) and sIgE</title><p>The rising trend of allergic diseases in the affluent populations in developed countries was alarming [<xref ref-type="bibr" rid="B19">19</xref>]. Investigations were carried out to find markers of allergy in such populations. The observation of high levels of tIgE in allergic individuals compared to healthy controls lead to identifying a cut-off level of tIgE for a diagnosis of allergy. It was observed that the probability is very high in predicting allergy when the tIgE level is above 200 kU/L [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. Longitudinal studies have demonstrated that levels of IgE increases with age from birth, regardless of atopic status but the increment in atopic children is abrupt and continue to have high levels in adult hood [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Since most somatic IgE is bound by its receptors, serum IgE may not necessarily reflect the systemic IgE levels. However, Dehlink and co-workers have been able to demonstrate that the level of serum IgE correlates well with cell-bound IgE [<xref ref-type="bibr" rid="B24">24</xref>]. Nevertherless, a high tIgE level alone is of limited value as a marker of allergy as it does not give any clue to sensitizing allergens in an individual. Hence, attention was paid more on sIgE as a biomarker.</p><p>The pool of IgE in an individual is the sum of IgE produced against different allergens - ie: specific IgE. Presence of sIgE in serum indicates that the individual has been exposed to the allergen earlier (sensitized). Presence of sIgE against a particular allergen above a level of 0.35 kU<sub>A</sub>/L is deemed positive for that allergen [<xref ref-type="bibr" rid="B10">10</xref>]. A person is said to be atopic if laboratory data shows a positive test. It should be noted that a positive result does not always correlate well with the clinical feature of a person. People with positive test for a particular allergen may not necessarily get symptoms when exposed to that allergen [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. Although, a positive test (a level &#x02265; 0.35 kU<sub>A</sub>/L) for aeroallergens generally correlates well with the clinical expression, much controversy exits for food allergens [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>]. The difficulty in defining a single reference value for all the food allergens has made doctors uncomfortable in interpreting reports. Different reference values for different food allergens have been suggested based on clinical evidence, but this makes the clinicians life extremely complicated when managing patients. Thus, well conducted cross-sectional and longitudinal studies are needed to reach a consensus in this regard.</p></sec><sec><title>IgE levels in populations in tropics</title><p>Recently, there had been much interest on how the allergic response is modulated by helminths in people living in helminth endemic areas of the tropics. Serum levels of tIgE are very high in such people despite being non-atopic [<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Indeed, it is observed that the tIgE levels are several folds higher in them compared to atopic people in the developed western countries emphasizing the limited use of tIgE as a marker of allergy in tropics [<xref ref-type="bibr" rid="B13">13</xref>]. It is known that helminths are capable of inducing IgE synthesis markedly [<xref ref-type="bibr" rid="B30">30</xref>]. Analysis of IgE molecules in such people has revealed that most of these IgE are non-specific [<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>]. It is postulated that polyclonal synthesis of IgE is a mechanism of the parasite to evade the host immune response against it [<xref ref-type="bibr" rid="B32">32</xref>]. The mechanism of immune evasion by helminths is not well elucidated to date. The observation of high tIgE and low sIgE levels in populations in tropics is interesting and needs to be explored since it reflects some of the facts related to the control of IgE synthesis.</p><p>Lynch et al have reported that helminths enhance the polyclonal synthesis of IgE resulting in high tIgE levels, while down-regulating the production of sIgE [<xref ref-type="bibr" rid="B32">32</xref>]. This suggests that control of tIgE and sIgE is independent from each other. Direct evidence for this comes from the study done by Sunyer and colleagues, which showed that tIgE levels are associated with asthma even in subjects negative for sIgE to common aeroallergens [<xref ref-type="bibr" rid="B33">33</xref>]. It should be noted that the population for the latter study comes from an area not endemic for helminth infections. Reinforcing this notion, genetic studies have revealed different genetic loci for tIgE levels and sIgE profiles [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B36">36</xref>].</p></sec><sec><title>Elevated tIgE in other diseases</title><p>The presence of high levels of tIgE in allergic diseases is well documented. Nevertheless, there are other situations where an increase in the level is observed. Hyper IgE syndrome, IgE myeloma, some disorders of vasculitis, though rare, should be considered in differential diagnosis for extremely high tIgE levels [<xref ref-type="bibr" rid="B37">37</xref>].</p></sec><sec><title>Therapeutic implications</title><p>The cornerstone of an allergic reaction is the cross-linking of IgE molecules bound to mast cell receptors. Neutralization of IgE antibodies is a conceptually new approach for the treatment of allergic diseases. Recombinant monoclonal humanized anti-IgE has demonstrated promising results as a treatment for asthma in adults [<xref ref-type="bibr" rid="B38">38</xref>]. Further studies are needed to evaluate long-term safety and efficacy in the treatment of allergic diseases with anti-IgE treatment in children [<xref ref-type="bibr" rid="B39">39</xref>].</p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Galli Lantz</surname><given-names>CS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><article-title>Allergy</article-title><source>Fundamenta immunology</source><year>1999</year><edition>4th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott-Raven</publisher-name><fpage>1127</fpage><lpage>1129</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennich</surname><given-names>HH</given-names></name><name><surname>Ishizaka</surname><given-names>K</given-names></name><name><surname>Johansson</surname><given-names>SGO</given-names></name><name><surname>Rowe</surname><given-names>DS</given-names></name><name><surname>Stanworth</surname><given-names>DR</given-names></name><name><surname>Terry</surname><given-names>WD</given-names></name></person-group><article-title>Immunoglobulin E, a new class of human immunoglobulin</article-title><source>Bull World Health Organ</source><year>1968</year><volume>38</volume><fpage>151</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">4174775</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>AK</given-names></name><name><surname>Lichtman</surname><given-names>AH</given-names></name></person-group><source>Basic iImmunology functions and disorders of the immune system</source><year>2004</year><edition>2nd ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Saunders</publisher-name></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seagroatt</surname><given-names>V</given-names></name><name><surname>Anderson</surname><given-names>SG</given-names></name></person-group><article-title>The second international reference preparation for human serum immunoglobulin E and the first British standard for human serum immunoglobulin E</article-title><source>J Biol Stand</source><year>1981</year><volume>9</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">7320024</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>S</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>New developments in FcepsilonRI regulation, function and inhibition</article-title><source>Nat Rev Immunol</source><year>2007</year><volume>7</volume><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">17438574</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Mukai</surname><given-names>K</given-names></name><name><surname>Minegishi</surname><given-names>Y</given-names></name><name><surname>Karasuyama</surname><given-names>H</given-names></name></person-group><article-title>Different stabilities of the structurally related receptors for IgE and IgG on the cell surface are determined by length of the stalk region in their &#x003b1;-chains</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>7008</fpage><lpage>7014</lpage><pub-id pub-id-type="pmid">16709862</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>HJ</given-names></name><name><surname>Sutton</surname><given-names>BJ</given-names></name></person-group><article-title>IgE in allergy and asthma today</article-title><source>Nat Rev Immunol</source><year>2008</year><volume>8</volume><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">18301424</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>SS</given-names></name><name><surname>Klion</surname><given-names>AD</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Hamilton</surname><given-names>RG</given-names></name><name><surname>Bochner</surname><given-names>BS</given-names></name><name><surname>MacGlashan</surname><given-names>DW</given-names><suffix>Jr</suffix></name></person-group><article-title>The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils</article-title><source>J Allergy Clin Immunol</source><year>2000</year><volume>106</volume><fpage>514</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">10984372</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieber</surname><given-names>T</given-names></name></person-group><article-title>Fc epsilon RII/CD23 on epidermal Langerhans' cells</article-title><source>Res Immunol</source><year>1992</year><volume>143</volume><fpage>445</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">1387722</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>SGO</given-names></name><name><surname>Bieber</surname><given-names>T</given-names></name><name><surname>Dahl</surname><given-names>R</given-names></name><name><surname>Friedmann</surname><given-names>PS</given-names></name><name><surname>Lanier</surname><given-names>BQ</given-names></name><name><surname>Lockey</surname><given-names>RF</given-names></name><name><surname>Motala</surname><given-names>C</given-names></name><name><surname>Ortega Martell</surname><given-names>JA</given-names></name><name><surname>Platts-Mills</surname><given-names>TA</given-names></name><name><surname>Ring</surname><given-names>J</given-names></name><name><surname>Thien</surname><given-names>F</given-names></name><name><surname>Van Cauwenberge</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>HC</given-names></name></person-group><article-title>Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>113</volume><fpage>832</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">15131563</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snow</surname><given-names>RE</given-names></name><name><surname>Chapman</surname><given-names>CJ</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Stevenson</surname><given-names>FK</given-names></name></person-group><article-title>Immunogenetics of human IgE</article-title><source>Hum Antibodies Hybridomas</source><year>1996</year><volume>7</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">9140727</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledin</surname><given-names>A</given-names></name><name><surname>Arnemo</surname><given-names>JM</given-names></name><name><surname>Liberg</surname><given-names>O</given-names></name><name><surname>Hellman</surname><given-names>L</given-names></name></person-group><article-title>High plasma IgE levels within the Scandinavian wolf population, and its implications for mammalian IgE homeostasis</article-title><source>Mol Immunol</source><year>2008</year><volume>45</volume><fpage>1976</fpage><lpage>1980</lpage><pub-id pub-id-type="pmid">18036664</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>ME</given-names></name><name><surname>Le Sou&#x000eb;f</surname><given-names>PN</given-names></name><name><surname>Motala</surname><given-names>C</given-names></name></person-group><article-title>Total IgE in urban Black South African teenagers: the influence of atopy and helminth infection</article-title><source>Pediatr Allergy Immunol</source><year>2008</year><volume>19</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">18221478</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkelman</surname><given-names>FD</given-names></name><name><surname>Urban</surname><given-names>JF</given-names><suffix>Jr</suffix></name></person-group><article-title>The other side of the coin: the protective role of the T<sub>H</sub>2 cytokines</article-title><source>J Allergy Clin Immunol</source><year>2001</year><volume>107</volume><fpage>772</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">11344341</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagan</surname><given-names>P</given-names></name></person-group><article-title>IgE and protective immunity to helminth infections</article-title><source>Parasite Immunol</source><year>1993</year><volume>15</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8433850</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>KJ</given-names></name><name><surname>Gleich</surname><given-names>GJ</given-names></name><name><surname>Checkel</surname><given-names>JL</given-names></name><name><surname>Loegering</surname><given-names>DA</given-names></name><name><surname>McCall</surname><given-names>JW</given-names></name><name><surname>Barker</surname><given-names>RL</given-names></name></person-group><article-title>In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins</article-title><source>J Immunol</source><year>1990</year><volume>144</volume><fpage>3166</fpage><lpage>3173</lpage><pub-id pub-id-type="pmid">2324497</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleich</surname><given-names>GJ</given-names></name><name><surname>Ottesen</surname><given-names>EA</given-names></name><name><surname>Leiferman</surname><given-names>KM</given-names></name><name><surname>Ackerman</surname><given-names>SJ</given-names></name></person-group><article-title>Eosinophils and human disease</article-title><source>Int Arch Allergy Appl Immunol</source><year>1989</year><volume>88</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2651320</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>AB</given-names></name></person-group><article-title>Allergy and allergic diseases. First of two parts</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11136958</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holgate</surname><given-names>ST</given-names></name></person-group><article-title>The epidemic of allergy and asthma</article-title><source>Nature</source><year>1999</year><volume>402</volume><issue>6760 Suppl</issue><fpage>B2</fpage><lpage>B4</lpage><pub-id pub-id-type="pmid">10586888</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carosso</surname><given-names>A</given-names></name><name><surname>Bugiani</surname><given-names>M</given-names></name><name><surname>Migliore</surname><given-names>E</given-names></name><name><surname>Ant&#x000f2;</surname><given-names>JM</given-names></name><name><surname>DeMarco</surname><given-names>R</given-names></name></person-group><article-title>Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults</article-title><source>Int Arch Allergy Immunol</source><year>2007</year><volume>142</volume><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">17108704</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittig</surname><given-names>HJ</given-names></name><name><surname>Belloit</surname><given-names>J</given-names></name><name><surname>De Fillippi</surname><given-names>I</given-names></name><name><surname>Royal</surname><given-names>G</given-names></name></person-group><article-title>Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease</article-title><source>J Allergy Clin Immunol</source><year>1980</year><volume>66</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">7419833</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherrill</surname><given-names>DL</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>Total serum IgE and its association with asthma symptoms and allergic sensitization among children</article-title><source>J Allergy Clin Immunol</source><year>1999</year><volume>104</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10400836</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickel</surname><given-names>R</given-names></name><name><surname>Illi</surname><given-names>S</given-names></name><name><surname>Lau</surname><given-names>S</given-names></name><name><surname>Sommerfeld</surname><given-names>C</given-names></name><name><surname>Bergmann</surname><given-names>R</given-names></name><name><surname>Kamin</surname><given-names>W</given-names></name><name><surname>Forster</surname><given-names>J</given-names></name><name><surname>Schuster</surname><given-names>A</given-names></name><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Wahn</surname><given-names>U</given-names></name></person-group><article-title>Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German Multicenter Allergy Study)</article-title><source>Clin Exp Allergy</source><year>2005</year><volume>35</volume><fpage>619</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">15898984</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehlink</surname><given-names>E</given-names></name><name><surname>Baker</surname><given-names>AH</given-names></name><name><surname>Yen</surname><given-names>E</given-names></name><name><surname>Nurko</surname><given-names>S</given-names></name><name><surname>Fiebiger</surname><given-names>E</given-names></name></person-group><article-title>Relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e12204</fpage><pub-id pub-id-type="pmid">20808937</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickman</surname><given-names>M</given-names></name></person-group><article-title>When allergies complicate allergies</article-title><source>Allergy</source><year>2005</year><volume>60</volume><issue>Suppl 79</issue><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">15842228</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastorello</surname><given-names>EA</given-names></name><name><surname>Incorvaia</surname><given-names>C</given-names></name><name><surname>Ortolani</surname><given-names>C</given-names></name><name><surname>Bonini</surname><given-names>S</given-names></name><name><surname>Canonica</surname><given-names>GW</given-names></name><name><surname>Romagnani</surname><given-names>S</given-names></name><name><surname>Tursi</surname><given-names>A</given-names></name><name><surname>Zanussi</surname><given-names>C</given-names></name></person-group><article-title>Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens</article-title><source>J Allergy Clin Immunol</source><year>1995</year><volume>96</volume><fpage>580</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">7499673</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miceli Sopo</surname><given-names>S</given-names></name><name><surname>Radzik</surname><given-names>D</given-names></name><name><surname>Calvani</surname><given-names>M</given-names></name></person-group><article-title>The predictive value of specific immunoglobulin E levels for the first diagnosis of cow's milk allergy. A critical analysis of pediatric literature</article-title><source>Pediatr Allergy Immunol</source><year>2007</year><volume>18</volume><fpage>575</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">17651374</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komata</surname><given-names>T</given-names></name><name><surname>S&#x000f6;derstr&#x000f6;m</surname><given-names>L</given-names></name><name><surname>Borres</surname><given-names>MP</given-names></name><name><surname>Tachimoto</surname><given-names>H</given-names></name><name><surname>Ebisawa</surname><given-names>M</given-names></name></person-group><article-title>Usefulness of wheat and soybean specific IgE antibod titers for the diagnosis of food allergy</article-title><source>Allergol Int</source><year>2009</year><volume>58</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">19776678</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wainstein</surname><given-names>BK</given-names></name><name><surname>Yee</surname><given-names>A</given-names></name><name><surname>Jelley</surname><given-names>D</given-names></name><name><surname>Ziegler</surname><given-names>M</given-names></name><name><surname>Ziegler</surname><given-names>JB</given-names></name></person-group><article-title>Combining skin prick, immediate skin application and specific-IgE testing in the diagnosis of peanut allergy in children</article-title><source>Pediatr Allergy Immunol</source><year>2007</year><volume>18</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">17433001</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>PJ</given-names></name><name><surname>Alexander</surname><given-names>N</given-names></name><name><surname>Moncayo</surname><given-names>AL</given-names></name><name><surname>Benitez</surname><given-names>SM</given-names></name><name><surname>Chico</surname><given-names>ME</given-names></name><name><surname>Vaca</surname><given-names>MG</given-names></name><name><surname>Griffin</surname><given-names>GE</given-names></name></person-group><article-title>Environmental determinants of total IgE among school children living in the rural Tropics: importance of geohelminth infections and effect of anthelmintic treatment</article-title><source>BMC Immunol</source><year>2008</year><volume>9</volume><fpage>33</fpage><pub-id pub-id-type="pmid">18588694</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagel</surname><given-names>I</given-names></name><name><surname>Lynch</surname><given-names>NR</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>M</given-names></name><name><surname>Di Prisco</surname><given-names>MC</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>R</given-names></name><name><surname>Rojas</surname><given-names>E</given-names></name></person-group><article-title>Modulation of the allergic reactivity of slum children by helminthic infection</article-title><source>Parasite Immunol</source><year>1993</year><volume>15</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">8361773</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>NR</given-names></name><name><surname>Hagel</surname><given-names>IA</given-names></name><name><surname>Palenque</surname><given-names>ME</given-names></name><name><surname>Di Prisco</surname><given-names>MC</given-names></name><name><surname>Escudero</surname><given-names>JE</given-names></name><name><surname>Corao</surname><given-names>LA</given-names></name><name><surname>Sandia</surname><given-names>JA</given-names></name><name><surname>Ferreira</surname><given-names>LJ</given-names></name><name><surname>Botto</surname><given-names>C</given-names></name><name><surname>Perez</surname><given-names>M</given-names></name><name><surname>Le Souef</surname><given-names>PN</given-names></name></person-group><article-title>Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment</article-title><source>J Allergy Clin Immunol</source><year>1998</year><volume>101</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">9500755</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunyer</surname><given-names>J</given-names></name><name><surname>Ant&#x000f3;</surname><given-names>JM</given-names></name><name><surname>Castellsagu&#x000e9;</surname><given-names>J</given-names></name><name><surname>Soriano</surname><given-names>JB</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name></person-group><article-title>Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma</article-title><source>Eur Respir J</source><year>1996</year><volume>9</volume><fpage>1880</fpage><lpage>1884</lpage><pub-id pub-id-type="pmid">8880106</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>PE</given-names></name><name><surname>Kabesch</surname><given-names>M</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Baldini</surname><given-names>M</given-names></name><name><surname>Fritzsch</surname><given-names>C</given-names></name><name><surname>Weiland</surname><given-names>SK</given-names></name><name><surname>Erickson</surname><given-names>RP</given-names></name><name><surname>von Mutius</surname><given-names>E</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children</article-title><source>J Allergy Clin Immunol</source><year>2000</year><volume>105</volume><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">10719301</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>DG</given-names></name><name><surname>Neely</surname><given-names>JD</given-names></name><name><surname>Breazeale</surname><given-names>DR</given-names></name><name><surname>Ghosh</surname><given-names>B</given-names></name><name><surname>Freidhoff</surname><given-names>LR</given-names></name><name><surname>Ehrlich-Kautzky</surname><given-names>E</given-names></name><name><surname>Schou</surname><given-names>C</given-names></name><name><surname>Krishnaswamy</surname><given-names>G</given-names></name><name><surname>Beaty</surname><given-names>TH</given-names></name></person-group><article-title>Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>1152</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">8178175</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansur</surname><given-names>AH</given-names></name><name><surname>Bishop</surname><given-names>DT</given-names></name><name><surname>Markham</surname><given-names>AF</given-names></name><name><surname>Morton</surname><given-names>NE</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Morrison</surname><given-names>JF</given-names></name></person-group><article-title>Suggestive evidence for genetic linkage between IgE phenotypes and chromosome 14q markers</article-title><source>Am J Respir Crit Care Med</source><year>1999</year><volume>159</volume><fpage>1796</fpage><lpage>1802</lpage><pub-id pub-id-type="pmid">10351921</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowicka</surname><given-names>U</given-names></name></person-group><article-title>Disorders with elevated immunoglobulin E levels</article-title><source>Pneumonol Alergol Pol</source><year>2009</year><volume>77</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">20013704</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milgrom</surname><given-names>H</given-names></name></person-group><article-title>Anti-IgE therapy in allergic disease</article-title><source>Curr Opin Pediatr</source><year>2004</year><volume>16</volume><fpage>642</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">15548927</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amato</surname><given-names>G</given-names></name><name><surname>Piccolo</surname><given-names>A</given-names></name><name><surname>Salzillo</surname><given-names>A</given-names></name><name><surname>Noschese</surname><given-names>P</given-names></name><name><surname>D'Amato</surname><given-names>M</given-names></name><name><surname>Liccardi</surname><given-names>G</given-names></name></person-group><article-title>A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma</article-title><source>Recent Pat Inflamm Allergy Drug Discov</source><year>2007</year><volume>1</volume><fpage>225</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">19075985</pub-id></element-citation></ref></ref-list></back></article>